Charles Schwab’s HI-TECH PHARMACAL INC HITK Stock Holding History

Charles Schwab’s Portfolio HITK Stock Details HITK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q2	–	Sell	-30,315	Closed	-$1.31M	–	3221
2014 Q1	$1.31M	Buy	30,315 +3,420	+13%	+$148K	﹤0.01%	2157
2013 Q4	$1.17M	Buy	26,895 +864	+3%	+$37.3K	﹤0.01%	2196
2013 Q3	$1.13M	Sell	26,031 -18,539	-42%	-$710K	﹤0.01%	2162
2013 Q2	$1.51M	Buy	+44,570	New	+$1.48M	﹤0.01%	1924

Charles Schwab's HITK Position: Q2 2014 in Review

Charles Schwab sold out of HI-TECH PHARMACAL INC (HITK) in Q2 2014, closing a stake of 30,315 shares — an estimated $1.31M sold.

Charles Schwab first reported a position in HITK in Q2 2013 and held it in 4 quarters. The position peaked at $1.51M in Q2 2013. 0 funds tracked by Wall St. Rank hold HITK as of Q2 2014.

Charles Schwab reported no remaining HI-TECH PHARMACAL INC position as of Q2 2014 after selling out during the quarter.
Charles Schwab sold 30,315 HI-TECH PHARMACAL INC shares in Q2 2014, an estimated $1.31M.
Charles Schwab first reported a position in HI-TECH PHARMACAL INC in Q2 2013 and held it in 4 quarters.
Charles Schwab's HI-TECH PHARMACAL INC position peaked at $1.51M in Q2 2013.
0 funds tracked by Wall St. Rank held HI-TECH PHARMACAL INC as of Q2 2014.

Based on Charles Schwab's 13F filing for Q2 2014, filed 30 Jul 2014.